Funding

ReAlta Life Sciences

United States · Biotech · Healthtech

Develops first-in-class peptides for inflammatory disorders

Visit realtalifesciences.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$40MParticipants not disclosed

Investors

No participants disclosed.

Coverage

Apr 8, 2026ReAlta Life Sciences · Undisclosed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesrealtalifesciences.com ↗